Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of July 18, 2012
  • Print
  • Share
  • E-mail
-
Back to Previous Page

Product Detail

Product Description Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18
Recall Number D-1412-2012
Classification Class II
Code Info Lot #0ZP5128 exp; 8/2013
Product Distributed Qty 14,465 bottles
Reason For Recall Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.

Event Detail

Event Id 62392
Product Type Drugs
Status Ongoing
Recalling Firm GlaxoSmithKline Inc
City Zebulon
State NC
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-06-04
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide
-
-